Market Express 2024: What is the latest selling price of venetoclax/venetoclax tablets?

Venetoclax, a drug that targets a specific type of leukemia, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) who have received at least one other prior treatment. In addition, the drug is also approved for use in combination with drugs such as azacitidine for the treatment of newly diagnosed acute myeloid leukemia patients aged 75 or older, as well as those who are unable to receive intensive induction chemotherapy due to comorbidities.

The original drug of venetoclax has been launched in China, and its common packaging specifications include 10mg 14 tablets, 50mg 7 tablets, 100mg 14 tablets and 100mg 4 tablets * 7 plates, etc. The selling prices of these medicines range from RMB 1,000 to RMB 4,000. It is worth mentioning that this drug has been included in Class B medical insurance, but only patients who meet the conditions for adult acute myeloid leukemia can enjoy reimbursement.

Venacla is also sold in the international market. For example, the Turkish version of the original drug, packaged in 100 mg and 112 tablets, costs more than 10,000 yuan (the price may change due to exchange rate fluctuations). In addition, there are generic drugs of Venetaclav in the overseas market. The ingredients of these drugs are basically the same as those of the original drugs sold at home and abroad. For example, the price of a 100 mg 120 tablet generic drug produced by a Lao pharmaceutical factory is about RMB 2,000 (the price may fluctuate due to exchange rates). Compared with the original drug, this price is obviously more affordable.